Bloomberg News (12/31, Feeley, Milford) reported, "Pfizer Inc. must pay $1.5 million in damages to a pharmacist who developed breast cancer after taking one of the company's menopause drugs, a jury in Puerto Rico ruled." Jurors found "that Pfizer's Wyeth subsidiary failed to properly warn Helen Rivera-Adams and her doctors about the health risks of its Prempro menopause medicine, one of her lawyers said." Over "6 million women took Prempro and related menopause drugs to treat symptoms such as hot flashes and mood swings before a 2002 study highlighted their links to cancer."
